ACS Applied Materials & Interfaces · 2018 · 79 citations · 36 references
PharmacyPharmaceuticsPharmacologyChemotherapyDrug DeliveryTargeted Drug DeliveryControlled Release MechanismsDrug Delivery EngineeringDrug EncapsulationNanocarriers For TherapeuticsNanomedicineNanoparticle FormulationsAnticancer Drug LoadingDrug Delivery NanocarriersDrug-loaded MicellesMicelle Drug DeliveryMicellesNanocarrier-based ProdrugsPolymer - Drug ConjugatesProdrug-drug Conjugates
Currently, tumor-targeted nanocarriers self-assembled from amphiphilic polymer-drug conjugates are of great demand. The appeal of these carriers arises mainly through their excellent loading efficiency of homologous drug molecules with microenvironment-triggered drug release. Herein, doxorubicin (DOX) was constructed to a hyaluronic acid (HA) backbone through hydrazone and disulfide linkages to construct pH and reduction coresponsive prodrug conjugates (HA-ss-DOX). During formulation, the amphipathic HA-ss-DOX spontaneously assembled into distinct core/shell micelles in aqueous media and showed conspicuous physical DOX loading capabilities (29.1%, DOX/HA-ss-DOX) based on homologous compatibility. DOX/HA-ss-DOX micelles were shown to be stable in normal physiological environments, while accomplishing selective, rapid DOX release at acidic pH and/or highly reducing conditions. The efficacy of DOX/HA-ss-DOX micelles was tested on A549 human lung cancer cells, wherein flow cytometry and confocal microscopy analysis revealed their HA receptor-mediated endocytosis mechanism. In comparison, DOX-loaded redox-insensitive micelles (DOX/HA-DOX) still demonstrated pH-dependent drug release. However, a more rapid intracellular DOX release profile was achieved in DOX/HA-ss-DOX micelles because of their sensitivity to both acidic and reducing environments. Resultantly, DOX/HA-ss-DOX exhibited the strongest cytotoxicity and apoptosis-inducing ability among all tested groups when tested on an A549 cell line and xenograft model.
36
Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels.
Periannan Kuppusamy, Haiquan Li, Govindasamy Ilangovan et al. · PubMed · 2002 · 688 citations
Medicine, Cancer Biology, Oncology +17